PRKAA1 and type 2 diabetes mellitus: Our findings provide another tool for understanding the allosteric activation of AMPK and suggest that the direct activation of AMPK is a promising approach for discovering novel therapies for the treatment of type 2 diabetes mellitus and metabolic diseases.